---
title: "Weekly Recap | Vnet -26.85%, hits 52-week low"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306362363.md"
description: "VNET fell 26.85% this week to close at $2.18, underperforming the S&P 500 by about 18.24 percentage points. The week was a one-way slide: Monday (16 November) opened at $2.86 and faded quickly, Wednesday (18 November) saw heavy selling with 14.5m shares traded, and Friday (20 November) touched a 52-week low of $2.01 before settling at $2.18. Weekly amplitude reached 29.72%, while average daily volume of 8.0m shares ran 53.52% above the 60-day median."
datetime: "2026-11-21T07:42:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306362363.md)
  - [en](https://longbridge.com/en/news/306362363.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306362363.md)
generator: "portal-rs"
---

# Weekly Recap | Vnet -26.85%, hits 52-week low

## The Week

VNET fell 26.85% this week to close at $2.18, underperforming the S&P 500 by about 18.24 percentage points. The week was a one-way slide: Monday (16 November) opened at $2.86 and faded quickly, Wednesday (18 November) saw heavy selling with 14.5m shares traded, and Friday (20 November) touched a 52-week low of $2.01 before settling at $2.18. Weekly amplitude reached 29.72%, while average daily volume of 8.0m shares ran 53.52% above the 60-day median.

## Key Events

Monday brought the appointment of Fuqiang Wang to the board, and the stock dropped over 16% in regular trading. Tuesday saw smaller losses. After-hours trading on Wednesday showed an 8% bounce, but the gain faded the next day when the stock fell another 8%. Thursday marked a fresh 52-week low during regular hours, and Friday’s pre-market pushed down to $2.13 before the close recovered to $2.18. No major business announcement or earnings release landed this week. The sell-off tracked broader weakness across Chinese ADRs and the cloud and data-centre space.

## Analyst Ratings

Among 15 institutions covering VNET, 11 rate it buy and 4 rate it outperform, with no hold, underweight or sell ratings. The consensus rating is strong buy, and the consensus target sits at $9.88, about 353.19% above the current price. Target prices range from $4.60 to $25.16, a wide spread that points to notable disagreement among analysts. Within the cloud and data-centre industry, VNET ranks 14th out of 31 names on broker ratings.

## The Week Ahead

VNET reports fiscal Q3 2026 earnings before market open on Monday (23 November). Consensus expects an EPS of -$0.0396 on revenue of $443m. The print will test how far current prices already discount the operating story. On Tuesday (24 November), the US releases FHFA house prices, Case Shiller 20-city home prices, consumer confidence and the Richmond Fed composite index, all of which may shape broad risk appetite.

## In Short

The stock hit a 52-week low this week. On the latest trading day, large-lot money was a net seller while medium and small orders were net buyers, showing a split in flows. Brokers still rate the name strong buy with a consensus target far above spot, though the target range is extremely wide. At about 1.03x book value, the stock trades near the bottom of its 60-day range. The next checkpoint is whether Monday’s earnings can deliver the revenue and narrowing-loss signals that the bullish ratings imply, and whether the broader sector can stabilise.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [VNET.US](https://longbridge.com/en/quote/VNET.US.md)

## Related News & Research

- [VNET Appoints Fuqiang Wang to Board](https://longbridge.com/en/news/305667373.md)
- [VNET Group (NASDAQ:VNET) SVP Zhihua Zhang Sells 28,740 Shares of Company Stock](https://longbridge.com/en/news/304127166.md)
- [Nasdaq (NDAQ) Just Gave Investors Something To Think About](https://longbridge.com/en/news/306370324.md)
- [Anthropic PBC (ANT) Claims Claude Solved The 167 Year Old Riemann Hypothesis](https://longbridge.com/en/news/306374461.md)
- [Have Insiders Sold Kestra Medical Technologies Shares Recently?](https://longbridge.com/en/news/306370330.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**